ChemoCentryx

YTD

ALL

Why Robinhood?

You can watch ChemoCentryx and buy or sell other stocks, options, and ETFs commission-free!

About CCXI

ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors.

CEO

David M. Reese, MD

CEODavid M. Reese, MD

Employees

—

Employees—

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1996

Founded1996

Employees

—

Employees—

CCXI Key Statistics

Market cap

3.71B

Market cap3.71B

Price-Earnings ratio

-27.56

Price-Earnings ratio-27.56

Dividend yield

—

Dividend yield—

Average volume

864.70K

Average volume864.70K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$52.00

52 Week high$52.00

52 Week low

$14.95

52 Week low$14.95